000-51598 | 77-0259335 | |
(Commission File Number) | (IRS Employer Identification No.) |
8 Crosby Drive, Bedford, Massachusetts | 01730 | |
(Address of Principal Executive Offices) | (Zip Code) |
99.1 | Press Release issued by the registrant on February 17, 2010, furnished herewith. |
iRobot Corporation |
||||
February 17, 2010 | By: | /s/ Glen D. Weinstein | ||
Name: | Glen D. Weinstein | |||
Title: | General Counsel and Secretary |
Exhibit Number | Description | |||
99.1 | Press Release issued by the registrant on February 17, 2010, furnished herewith. |
Contacts: |
||
Elise Caffrey
|
Nancy Smith | |
Investor Relations
|
Media Relations | |
iRobot Corp.
|
iRobot Corp. | |
(781) 430-3003
|
(781) 430-3323 | |
ecaffrey@irobot.com
|
nsmith@irobot.com |
| International home robot revenue in 2009 increased 35.2 percent from 2008 and comprised more than half of total home robot revenue for the year. | |
| Government & Industrial Robots revenue increased 10.7 percent in the fourth quarter over last year and ended the year with a record $42 million in product backlog. | |
| In 2009, operating cash flow was $40.6 million, compared with $19.1 million in 2008, as a result of improved Adjusted EBITDA and aggressive working capital management. |
Fiscal Year 2010: |
||
Revenue
|
$345 $360 million | |
Adjusted EBITDA
|
$24 $28 million | |
Earnings Per Share
|
$0.20 $0.25 | |
Q1 2010: |
||
Revenue
|
$82 $87 million | |
Adjusted EBITDA
|
$4 $6 million | |
Earnings Per Share
|
$0.01 $0.04 |
Date: |
Thursday, Feb. 18, 2010 | |||
Time: |
8:30 a.m. EST | |||
Call-In Number: |
617-213-8857 | |||
Passcode: |
17983347 |
For the three months ended | For the twelve months ended | |||||||||||||||
January 2, | December 27, | January 2, | December 27, | |||||||||||||
2010 | 2008 | 2010 | 2008 | |||||||||||||
Revenue |
||||||||||||||||
Product revenue |
$ | 90,819 | $ | 82,712 | $ | 262,199 | $ | 281,187 | ||||||||
Contract revenue |
10,903 | 7,990 | 36,418 | 26,434 | ||||||||||||
Total |
101,722 | 90,702 | 298,617 | 307,621 | ||||||||||||
Cost of Revenue |
||||||||||||||||
Product revenue |
59,679 | 51,302 | 176,631 | 190,250 | ||||||||||||
Contract revenue |
7,657 | 6,687 | 30,790 | 23,900 | ||||||||||||
Total |
67,336 | 57,989 | 207,421 | 214,150 | ||||||||||||
Gross Margin |
34,386 | 32,713 | 91,196 | 93,471 | ||||||||||||
Operating Expense |
||||||||||||||||
Research & development |
4,114 | 3,935 | 14,747 | 17,566 | ||||||||||||
Selling & marketing |
13,482 | 11,415 | 40,902 | 46,866 | ||||||||||||
General & administrative |
8,195 | 7,144 | 30,110 | 28,840 | ||||||||||||
Total |
25,791 | 22,494 | 85,759 | 93,272 | ||||||||||||
Operating income |
8,595 | 10,219 | 5,437 | 199 | ||||||||||||
Other income (expense), net |
15 | 9 | (81 | ) | 926 | |||||||||||
Pre-tax income |
8,610 | 10,228 | 5,356 | 1,125 | ||||||||||||
Income tax expense |
3,478 | 4,806 | 2,026 | 369 | ||||||||||||
Net income |
$ | 5,132 | $ | 5,422 | $ | 3,330 | $ | 756 | ||||||||
Net income per common share: |
||||||||||||||||
Basic |
$ | 0.20 | $ | 0.22 | $ | 0.13 | $ | 0.03 | ||||||||
Diluted |
$ | 0.20 | $ | 0.21 | $ | 0.13 | $ | 0.03 | ||||||||
Shares used in Per Common Share Calculations: |
||||||||||||||||
Basic |
25,059 | 24,775 | 24,998 | 24,654 | ||||||||||||
Diluted |
25,837 | 25,451 | 25,640 | 25,533 | ||||||||||||
Stock-based compensation included in above figures: |
||||||||||||||||
Cost of product revenue |
$ | 369 | $ | 199 | $ | 1,127 | $ | 753 | ||||||||
Cost of contract revenue |
111 | 162 | 575 | 462 | ||||||||||||
Research & development |
164 | 133 | 351 | 359 | ||||||||||||
Selling & marketing |
404 | 322 | 1,410 | 1,055 | ||||||||||||
General & administrative |
1,155 | 815 | 4,099 | 3,310 | ||||||||||||
Total |
$ | 2,203 | $ | 1,631 | $ | 7,562 | $ | 5,939 | ||||||||
January 2, | December 27, | |||||||
2010 | 2008 | |||||||
Assets |
||||||||
Cash and equivalents |
$ | 71,856 | $ | 40,852 | ||||
Short term investments |
4,959 | | ||||||
Accounts receivable, net |
35,171 | 35,930 | ||||||
Unbilled revenues |
1,831 | 2,014 | ||||||
Inventory |
32,406 | 34,560 | ||||||
Deferred tax assets |
8,669 | 7,299 | ||||||
Other current assets |
4,119 | 3,340 | ||||||
Total current assets |
159,011 | 123,995 | ||||||
Property, plant and equipment, net |
20,230 | 22,929 | ||||||
Deferred tax assets |
6,089 | 4,508 | ||||||
Other assets |
14,254 | 12,246 | ||||||
Total assets |
$ | 199,584 | $ | 163,678 | ||||
Liabilities and stockholders equity |
||||||||
Accounts payable |
$ | 30,559 | $ | 19,544 | ||||
Accrued expenses |
14,384 | 10,989 | ||||||
Accrued compensation |
13,525 | 6,393 | ||||||
Deferred revenue and customer advances |
3,908 | 2,632 | ||||||
Total current liabilities |
62,376 | 39,558 | ||||||
Long term liabilities |
4,014 | 4,444 | ||||||
Stockholders equity |
133,194 | 119,676 | ||||||
Total liabilities and stockholders equity |
$ | 199,584 | $ | 163,678 | ||||
For the three months ended | For the twelve months ended | |||||||||||||||
January 2, | December 27, | January 2, | December 27, | |||||||||||||
2010 | 2008 | 2010 | 2008 | |||||||||||||
Cash flows from operating
activities: |
||||||||||||||||
Net income |
$ | 5,132 | $ | 5,422 | $ | 3,330 | $ | 756 | ||||||||
Adjustments to reconcile net
income to net cash provided
by operating activities: |
||||||||||||||||
Depreciation and
amortization |
1,921 | 1,894 | 8,074 | 7,029 | ||||||||||||
Loss on disposal of
property and
equipment |
26 | 151 | 202 | 231 | ||||||||||||
Stock-based
compensation |
2,203 | 1,631 | 7,562 | 5,939 | ||||||||||||
In-process research
and development
relating to
acquisition of
Nekton Research LLC |
| | | 200 | ||||||||||||
Benefit from
deferred tax assets |
(2,970 | ) | (1,967 | ) | (3,317 | ) | (1,967 | ) | ||||||||
Non-cash director
deferred
compensation |
33 | 24 | 132 | 95 | ||||||||||||
Changes in operating assets
and liabilities (use)
source |
||||||||||||||||
Accounts receivable |
8,763 | 10,391 | 759 | 12,221 | ||||||||||||
Unbilled revenue |
706 | 258 | 183 | 230 | ||||||||||||
Inventory |
(7,753 | ) | 8,036 | 2,154 | 10,662 | |||||||||||
Other assets |
295 | 5,888 | (816 | ) | (1,042 | ) | ||||||||||
Accounts payable |
2,772 | (11,810 | ) | 11,015 | (25,350 | ) | ||||||||||
Accrued expenses |
2,712 | 1,597 | 3,385 | 3,002 | ||||||||||||
Accrued compensation |
2,679 | (1,869 | ) | 7,132 | 1,634 | |||||||||||
Deferred revenue |
(336 | ) | (101 | ) | 1,276 | 1,026 | ||||||||||
Long term liabilities |
(108 | ) | (108 | ) | (430 | ) | 4,444 | |||||||||
Net cash provided by
operating activities |
16,075 | 19,437 | 40,641 | 19,110 | ||||||||||||
Cash flows from investing
activities: |
||||||||||||||||
Additions of property and
equipment |
(1,637 | ) | (1,228 | ) | (5,038 | ) | (14,817 | ) | ||||||||
Purchase of Nekton Research
LLC, net of cash received |
(2,500 | ) | 2 | (2,500 | ) | (9,743 | ) | |||||||||
Purchases of investments |
(5,000 | ) | | (5,000 | ) | (29,997 | ) | |||||||||
Sales of investments |
| 16,197 | | 46,547 | ||||||||||||
Net cash provided by (used
in) investing activities |
(9,137 | ) | 14,971 | (12,538 | ) | (8,010 | ) | |||||||||
Cash flows from financing
activities: |
||||||||||||||||
Proceeds from stock option
exercises |
243 | 103 | 738 | 1,011 | ||||||||||||
Income tax withholding
payment associated with
restricted stock vesting |
| | (76 | ) | | |||||||||||
Borrowings under revolving
line of credit |
| | | 5,500 | ||||||||||||
Repayment of borrowings
under revolving line of
credit |
| (5,500 | ) | | (5,500 | ) | ||||||||||
Tax benefit of excess stock
based compensation
deductions |
1,928 | 1,326 | 2,239 | 2,006 | ||||||||||||
Net cash provided by (used
in) financing activities |
2,171 | (4,071 | ) | 2,901 | 3,017 | |||||||||||
Net increase in cash and
cash equivalents |
9,109 | 30,337 | 31,004 | 14,117 | ||||||||||||
Cash and cash equivalents,
at beginning of period |
62,747 | 10,515 | 40,852 | 26,735 | ||||||||||||
Cash and cash equivalents,
at end of period |
$ | 71,856 | $ | 40,852 | $ | 71,856 | $ | 40,852 | ||||||||
For the three months ended | For the twelve months ended | |||||||||||||||
January 2, | December 27, | January 2, | December 27, | |||||||||||||
2010 | 2008 | 2010 | 2008 | |||||||||||||
Revenue by business unit (in
thousands): |
||||||||||||||||
Home Robots |
||||||||||||||||
Product |
$ | 54,607 | $ | 48,123 | $ | 165,860 | $ | 173,547 | ||||||||
Contract |
| | | 55 | ||||||||||||
Government & Industrial |
||||||||||||||||
Product |
36,212 | 34,589 | 96,339 | 107,640 | ||||||||||||
Contract |
10,903 | 7,990 | 36,418 | 26,379 | ||||||||||||
$ | 101,722 | $ | 90,702 | $ | 298,617 | $ | 307,621 | |||||||||
Direct Revenue Home Robots
(in thousands) |
$ | 8,377 | $ | 8,183 | $ | 25,555 | $ | 30,697 | ||||||||
Product Lifecycle Revenue -
Government & Industrial (in
thousands) |
$ | 9,356 | $ | 8,652 | $ | 23,655 | $ | 20,004 | ||||||||
International Revenue (in
thousands): |
||||||||||||||||
Home Robots |
$ | 29,870 | $ | 23,159 | $ | 89,166 | $ | 65,942 | ||||||||
Government & Industrial |
$ | 1,129 | $ | 475 | $ | 10,222 | $ | 6,045 | ||||||||
Average selling prices for
robot units: |
||||||||||||||||
Home Robots |
$ | 156 | $ | 150 | $ | 154 | $ | 150 | ||||||||
Government & Industrial
(in thousands) |
$ | 82 | $ | 85 | $ | 92 | $ | 92 | ||||||||
Gross Margin by business unit
(in thousands): |
||||||||||||||||
Home Robots |
$ | 19,720 | $ | 16,074 | $ | 53,431 | $ | 49,769 | ||||||||
Government & Industrial |
14,666 | 16,639 | 37,765 | 43,702 | ||||||||||||
$ | 34,386 | $ | 32,713 | $ | 91,196 | $ | 93,471 | |||||||||
Units shipped by business unit: |
||||||||||||||||
Home Robots (in thousands) |
324 | 293 | 988 | 1,054 | ||||||||||||
Government & Industrial |
329 | 306 | 789 | 951 | ||||||||||||
Government & Industrial Funded
Backlog (in thousands) |
$ | 42,160 | $ | 8,401 | $ | 42,160 | $ | 8,401 | ||||||||
Days sales outstanding |
33 | 38 | 33 | 38 | ||||||||||||
Inventory turnover |
7.4 | 6.0 | 7.4 | 6.0 | ||||||||||||
Net cash provided by operating
activities (in thousands) |
$ | 16,075 | $ | 19,437 | $ | 40,641 | $ | 19,110 | ||||||||
Headcount |
538 | 479 | 538 | 479 |
For the three months ended | For the twelve months ended | |||||||||||||||
January 2, | December 27, | January 2, | December 27, | |||||||||||||
2010 | 2008 | 2010 | 2008 | |||||||||||||
Net income |
$ | 5,132 | $ | 5,422 | $ | 3,330 | $ | 756 | ||||||||
Interest income, net |
(47 | ) | (77 | ) | (88 | ) | (1,111 | ) | ||||||||
Income tax expense |
3,478 | 4,806 | 2,026 | 369 | ||||||||||||
Depreciation |
1,782 | 1,771 | 7,545 | 6,865 | ||||||||||||
Amortization |
139 | 123 | 529 | 164 | ||||||||||||
EBITDA |
10,484 | 12,045 | 13,342 | 7,043 | ||||||||||||
Stock-based compensation expense |
2,203 | 1,631 | 7,562 | 5,939 | ||||||||||||
Adjusted EBITDA |
$ | 12,687 | $ | 13,676 | $ | 20,904 | $ | 12,982 | ||||||||